Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Peter W. M. Chung"'
Autor:
Nicola J, Nasser, Elantholi P, Saibishkumar, Yinkun, Wang, Peter W M, Chung, Stephen L, Breen
Publikováno v:
Journal of Contemporary Brachytherapy. 14:354-363
Variations in dosimetric outcomes among patients treated with low-dose-rate brachytherapy for prostate cancer exist, even when implants are within dose constraints. Here, we used control charts to investigate reasons for intra-patient dosimetric vari
Autor:
Srikala S. Sridhar, Nicholas Power, Rodney H. Breau, Susanna Y. Cheng, Gregory Russell Pond, Peter W. M. Chung, Ur Metser, Mark Norman Levine, Som D. Mukherjee
Publikováno v:
Journal of Clinical Oncology. 41:460-460
460 Background: Muscle invasive bladder cancer (MIBC) is an aggressive local disease where initial staging with conventional CT imaging is often suboptimal. To explore the role of PET-CT in both staging MIBC and assessing response to neoadjuvant chem
Autor:
Abdulazeez Salawu, Elizabeth Demicco, Peter W. M. Chung, Jordan Feeney, Jasmine Lee, Eoghan Ruadh Malone, Charles Catton, Limore Arones, Madeline J. Phillips, Philip Wong, Jay Wunder, Peter Charles Ferguson, Stephen Willingham, David Benjamin Shultz, Albiruni Ryan Abdul Razak
Publikováno v:
Journal of Clinical Oncology. 40:11547-11547
11547 Background: Surgery and (neo)adjuvant radiotherapy are the mainstay curative treatments for localized STS. Despite treatment, approximately 50% of STS patients (pts) experience metastatic relapse and routine use of adjuvant systemic therapy (AS
Autor:
Alexandre R. Zlotta, Leslie K. Ballas, Andrzej Niemierko, Katherine Lajkosz, Cynthia Kuk, Gus Miranda, Michael Drumm, Andrea Mari, Neil E. Fleshner, Girish S. Kulkarni, Peter W. M. Chung, Robert G. Bristow, Srikala S. Sridhar, Adam S. Feldman, Matthew Wszolek, Richard J. Lee, Anthony L. Zietman, William U. Shipley, Siamak Daneshmand, Jason A. Efstathiou
Publikováno v:
Journal of Clinical Oncology. 40:433-433
433 Background: Prior randomized controlled trials (RCT) comparing bladder preservation to radical cystectomy (RC) for muscle invasive bladder cancer (MIBC) closed early due to lack of accrual. Given that no future RCTs are foreseen, and in the absen
Autor:
Esmail Mutahar Al-Ezzi, Abhenil Mittal, Brooke Wilson, Marco Iafolla, Srikala S. Sridhar, Adrian G. Sacher, Nazanin Fallah-Rad, Charles Catton, Peter W. M. Chung, Nathan Perlis, Aaron Richard Hansen
Publikováno v:
Journal of Clinical Oncology. 40:332-332
332 Background: Patients (pts) with mRCC with SD have unfavorable outcomes and poor prognosis due to aggressive tumor behavior. Chemotherapy and targeted treatment are often of little benefit. However, recent studies have shown a survival benefit of
Autor:
Esmail Mutahar Al-Ezzi, Abhenil Mittal, Brooke Wilson, Marco Iafolla, Pavlina Spiliopoulou, Srikala S. Sridhar, Nazanin Fallah-Rad, Peter W. M. Chung, Nathan Perlis, Aaron Richard Hansen
Publikováno v:
Journal of Clinical Oncology. 40:333-333
333 Background: Patients (pts) diagnosed with metastatic renal cell carcinoma (mRCC) with rhabdoid differentiation (RD) have a poor prognosis due to aggressive tumor behavior and inherent treatment resistance to targeted therapies. However, recent da
Autor:
Abhenil Mittal, Esmail Mutahar Al-Ezzi, Xuan Li, Brooke Wilson, Pavlina Spiliopoulou, Srikala S. Sridhar, Nazanin Fallah-Rad, Peter W. M. Chung, Robert James Hamilton, Aaron Richard Hansen
Publikováno v:
Journal of Clinical Oncology. 40:345-345
345 Background: Patients (pts) with metastatic renal cell carcinoma (mRCC) and tumor thrombus have historically been treated with cytoreductive nephrectomy (CN), however, their outcomes remain poor. Recent phase III data suggest the role for cytoredu
Autor:
Olga Vornicova, Jay Wunder, Peter W. M. Chung, Abha A. Gupta, Rebecca Anne Gladdy, Charles N. Catton, Samer Salah, Peter Charles Ferguson, Kim Tsoi, David Benjamin Shultz, Savtaj Singh Brar, Philip Wong, Carol Jane Swallow, Albiruni Ryan Abdul Razak, Esmail Mutahar Al-Ezzi
Publikováno v:
Journal of Clinical Oncology. 39:11548-11548
11548 Background: The mainstay therapy of operable STS remains surgery, which may include (neo)adjuvant therapies. Within the TSP, marginally inoperable STS are often treated with sequential chemo (CTX) and radiation (RT) therapy, followed by surgery
Autor:
Samer Salah, Anthony Lott, Peter Charles Ferguson, Jay Wunder, Abha A. Gupta, Charles N Catton, Brian O'Sullivan, Carol Jane Swallow, Peter W. M. Chung, Eitan Amir, Albiruni R Abdul Razak
Publikováno v:
Journal of Clinical Oncology. 34:11051-11051
Autor:
Brian, O'Sullivan, Anthony M, Griffin, Colleen I, Dickie, Michael B, Sharpe, Peter W M, Chung, Charles N, Catton, Peter C, Ferguson, Jay S, Wunder, Benjamin M, Deheshi, Lawrence M, White, Rita A, Kandel, David A, Jaffray, Robert S, Bell
Publikováno v:
Cancer. 119(10)
This study sought to determine if preoperative image-guided intensity-modulated radiotherapy (IG-IMRT) can reduce morbidity, including wound complications, by minimizing dose to uninvolved tissues in adults with lower extremity soft tissue sarcoma.Th